HE is caught in an uncomfortable divergence: short sellers are gradually covering, options traders have turned notably more bullish, and yet the stock keeps sliding — down 2.4% on the week and 14% over the past month to $11.56 — while almost every peer in the utility space has moved higher.
The options market is sending a clearer directional signal than usual. The put/call ratio has dropped to 0.36, roughly 1.5 standard deviations below its 20-day average of 0.43 — a reading that implies calls are now well outnumbering puts, the most bullish options skew seen in months. That shift happened abruptly around August 11, when the PCR broke from a plateau near 0.45 that had held for six consecutive weeks. The move is notable because it arrived just days after the Q2 earnings print, suggesting some participants are positioning for a recovery rather than adding more downside insurance.
Short positioning tells a more cautious but less extreme story. Short interest has edged down nearly 6% on the week to 9.1% of the free float — a meaningful level for the sector, but off a recent peak above 10% seen in early July when it briefly touched 18 million shares. Borrow remains cheap at roughly 0.49%, and availability is wide at around 473% of short interest, meaning there are more than four shares available to borrow for every one currently lent out. That relaxed lending environment removes any squeeze threat in the near term. The ORTEX short score of 61.4 is firm but has eased slightly from its recent high of 62.6 on August 10 — not a dramatic shift, but consistent with bears trimming rather than adding.
Analyst sentiment is skewed negative and has been drifting lower. Barclays cut its target to $12 from $13 this week — the third successive reduction from that desk — while Jefferies, which downgraded to Underperform back in January, trimmed its target to $11.75 in July. Both firms are essentially flat on the stock near current prices, leaving little implied upside from the consensus mean target of around $11.92. The factor picture adds colour: the EPS surprise rank is exceptional at the 98th percentile, but forward EPS momentum is deeply negative, ranking in just the 7th percentile on a 30-day basis and the 11th on a 90-day basis. That combination — beating a lowered bar — is the hallmark of a de-rating story rather than an earnings recovery.
The institutional ownership picture has one detail worth noting. Horizon Kinetics holds nearly 13% of shares, a concentrated and largely illiquid position that has grown by around 760,000 shares in the most recently reported quarter. BlackRock added over 736,000 shares in the same period. Both are large, patient holders — their continued accumulation provides a structural floor, but neither is likely to be a near-term catalyst.
The most recent earnings print underscores the pattern the stock keeps repeating: Q2 results on August 7 sent the stock down 6.5% in a single session and it has continued lower in the five days since, a 6.1% loss over the full post-earnings window. Peer utilities PNW, EVRG, and AEP have each gained between 1% and 2.2% this week, making HE's underperformance hard to attribute to sector rotation alone. The next earnings event is scheduled for November 6 — the gap between now and then means the stock lives or dies on news flow around Hawaii wildfire litigation, rate case progress, and any revision to the forward earnings trajectory. The tension between a relatively bullish options setup and persistent price weakness is what makes this name worth watching closely heading into autumn.
See the live data behind this article on ORTEX.
Open HE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
